These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16418541)

  • 21. Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
    Padwal RS; Majumdar SR
    Lancet; 2007 Jan; 369(9555):71-7. PubMed ID: 17208644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug treatment of obesity].
    Burniat W
    Rev Med Brux; 2009; 30(2):124-6. PubMed ID: 19517912
    [No Abstract]   [Full Text] [Related]  

  • 23. [New treatments for obesity].
    Féry F; Watrin I
    Rev Med Brux; 1999 Sep; 20(4):A381-5. PubMed ID: 10523928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.
    Norris SL; Zhang X; Avenell A; Gregg E; Schmid CH; Lau J
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004096. PubMed ID: 15674929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
    Coutinho W
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy for obesity.
    Neff LM; Aronne LJ
    Curr Atheroscler Rep; 2007 Dec; 9(6):454-62. PubMed ID: 18377785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.
    Norris SL; Zhang X; Avenell A; Gregg E; Schmid CH; Kim C; Lau J
    Arch Intern Med; 2004 Jul; 164(13):1395-404. PubMed ID: 15249348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort.
    Douglas IJ; Bhaskaran K; Batterham RL; Smeeth L
    Br J Clin Pharmacol; 2015 Jun; 79(6):1020-7. PubMed ID: 25641659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic agents for the treatment of obesity.
    Mathys M
    Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO
    MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and emerging pharmacotherapies for obesity in Australia.
    Hocking S; Dear A; Cowley MA
    Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for obesity.
    Halford JC
    Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safe and effective management of the obese patient.
    Collazo-Clavell ML
    Mayo Clin Proc; 1999 Dec; 74(12):1255-9; quiz 1259-60. PubMed ID: 10593355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New options for drug treatment of obesity in patients with Type 2 diabetes.
    Kennedy RL; Khoo EY
    Diabet Med; 2005 Sep; 22 Suppl 4():23-6. PubMed ID: 16109016
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review.
    Neovius M; Narbro K
    Int J Obes (Lond); 2008 Dec; 32(12):1752-63. PubMed ID: 18982009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing obesity like any other chronic condition. Long-term therapy may reduce comorbidity as well.
    Agrawal M; Worzniak M; Diamond L
    Postgrad Med; 2000 Jul; 108(1):75-6, 79-82. PubMed ID: 10914120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug treatment of the overweight patient.
    Bray GA; Ryan DH
    Gastroenterology; 2007 May; 132(6):2239-52. PubMed ID: 17498515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy for obesity.
    Li M; Cheung BM
    Br J Clin Pharmacol; 2009 Dec; 68(6):804-10. PubMed ID: 20002075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
    Zieba R
    Postepy Hig Med Dosw (Online); 2007 Oct; 61():612-26. PubMed ID: 17971763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.